Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia

Fiona C Brown, Xin Wang, Richard W Birkinshaw, Chong Chyn Chua, Thomas David Morley, Sila Kasapgil, Giovanna Pomilio, Piers Blombery, David Ching Siang Huang, Professor, Peter E Czabotar, Salvatore F Priore, Guang Yang, Martin P. Carroll, Andrew H. Wei, Alexander E. Perl

Blood Adv bloodadvances.2024014446.

https://doi.org/10.1182/bloodadvances.2024014446

Published: 2024

Includes: Supplemental data

Journal Articles

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar I. Gill, David L. Porter, Daria V. Babushok, Ivan P. Maillard, Martin P. Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei-Ting Hwang, David Margolis, Keith W. Pratz

Blood Adv (2022) 6 (13): 3997–4005.

https://doi.org/10.1182/bloodadvances.2022007265

Published: 2022

Includes: Supplemental data